prednisolone has been researched along with Autoimmune Lymphoproliferative Syndrome in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Autoimmune Lymphoproliferative Syndrome: Rare congenital lymphoid disorder due to mutations in certain Fas-Fas ligand pathway genes. Known causes include mutations in FAS, TNFSF6, NRAS, CASP8, and CASP10 proteins. Clinical features include LYMPHADENOPATHY; SPLENOMEGALY; and AUTOIMMUNITY.
Excerpt | Relevance | Reference |
---|---|---|
"It presents as lymphadenopathy, hepatosplenomegaly and autoimmune phenomena." | 1.42 | Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia. ( Bisht, S; Meena, KR; Tamaria, KC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ruan, YS | 1 |
He, YL | 1 |
Feng, XQ | 1 |
Meena, KR | 1 |
Bisht, S | 1 |
Tamaria, KC | 1 |
Ben-Chetrit, E | 1 |
Bnaya, A | 1 |
Vernea, F | 1 |
Somech, R | 1 |
Ashkenazi, YJ | 1 |
3 other studies available for prednisolone and Autoimmune Lymphoproliferative Syndrome
Article | Year |
---|---|
[Autoimmune lymphoproliferative syndrome: a case report].
Topics: Autoimmune Lymphoproliferative Syndrome; Biomarkers; Child, Preschool; fas Receptor; Humans; Male; M | 2013 |
Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia.
Topics: Autoimmune Lymphoproliferative Syndrome; Biopsy, Fine-Needle; Child; Diagnosis, Differential; Drug A | 2015 |
Sometimes double negative is positive.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Au | 2013 |